Pharmaceuticals market research reports by GlobalData

• Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 provides an overview of Wet (Neovascular / Exudative) Macular Degeneration Cl ... Read More

• Amyloidosis - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Amyloidosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Amyloidosis - Global Clinical Trials Review, 2024 provides an overview of Amyloidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report inc ... Read More

• Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024

  Apr 24, 2024  |  Published by: GlobalData  |  USD 2,500

  Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) - Global Clinical Trials Review, 2024 provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line ... Read More

• New Prescription - Generative AI meets Healthcare (Vol. 2)

  Apr 22, 2024  |  Published by: GlobalData  |  USD 995

  New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More

• Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs

  Apr 19, 2024  |  Published by: GlobalData  |  USD 295

  Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs Summary This comprehensive conversation analysis report delves into the most popular weight loss drugs on Reddit in the last six months (October 1st, 2023, to March 31st, 2024), offering a nuanced understanding of their prominence and po ... Read More

• Digital Marketing Trends in Inflammatory Bowel Disease - April 2024

  Apr 17, 2024  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Inflammatory Bowel Disease - April 2024 Summary AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 1.8 million visitors from March 2023 to February 2024. This was followed by AbbVie’s Rinvoq.c ... Read More

• Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033

  Apr 16, 2024  |  Published by: GlobalData  |  USD 3,995

  Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033 Summary Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality (Vázquez-Sánchez et al., 2022). MRSA can ... Read More

• Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector

  Apr 16, 2024  |  Published by: GlobalData  |  USD 995

  Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Thematic Intelligence: Net Zero Strategies in the Pharmaceutical Sector Summary Companies achieve net zero emissions by cutting greenhouse gas emissions to as close to zero as possible, with any remaining emissions then “offset. ... Read More

• New Drug Approvals and Their Contract Manufacture - 2024 Edition

  Apr 16, 2024  |  Published by: GlobalData  |  USD 4,995

  New Drug Approvals and Their Contract Manufacture - 2024 Edition Summary This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called CMO Sco ... Read More

• Acne Vulgaris (AV) - Competitive Landscape

  Apr 15, 2024  |  Published by: GlobalData  |  USD 3,495

  Acne Vulgaris (AV) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AV therapeutics. GlobalData epidemiologists estimated more than 403 million diagnosed prevalent cases of AV in 2023 in the 16 countries covered in Global ... Read More

• Colibri Heart Valve LLC - Product Pipeline Analysis, 2023 Update

  Apr 08, 2024  |  Published by: GlobalData  |  USD 750

  Summary Colibri Heart Valve LLC (Colibri Heart Valve) is a privately held medical device company that researches and develops novel, patent-protected, and structural heart technologies. The company’s products include Colibri transcatheter aortic valve implantation system, pipeline products and clini ... Read More

• Resistant Hypertension (RH) - Competitive Landscape

  Apr 05, 2024  |  Published by: GlobalData  |  USD 3,495

  Resistant Hypertension (RH) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RH therapeutics. GlobalData epidemiologists estimated more than 79 million diagnosed prevalent cases of RH in 2023 in the 16 countries covered i ... Read More

• Psychedelics Therapeutics Development and Trends, 2024

  Apr 05, 2024  |  Published by: GlobalData  |  USD 495

  Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More

• Retinitis Pigmentosa (RP) - Competitive Landscape

  Mar 31, 2024  |  Published by: GlobalData  |  USD 3,495

  Retinitis Pigmentosa (RP) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in RP therapeutics. More than 1,000,000 diagnosed prevalent cases of RP are expected in 2024 in the 16 countries covered in GlobalData’s epidemiology ... Read More

• Peripheral Artery Disease (PAD): Competitive Landscape

  Mar 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Peripheral Artery Disease (PAD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PAD therapeutics. More than 18,000,000 diagnosed prevalent cases of PAD are expected in 2024 in the 16 countries covered in GlobalData’s epid ... Read More

• Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape

  Mar 29, 2024  |  Published by: GlobalData  |  USD 3,495

  Fuchs Endothelial Corneal Dystrophy (FECD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in FECD therapeutics. More than 133,000,000 total prevalent cases of FECD are expected in 2024 in the 16 countries covered in GlobalD ... Read More

• Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  Mar 29, 2024  |  Published by: GlobalData  |  USD 4,000

  Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Breast Implants Pipeline Report including Stages of Development, Segments, Region and Countries, Regula ... Read More

• Cell and Gene Therapies in Ophthalmology

  Mar 28, 2024  |  Published by: GlobalData  |  USD 6,995

  Cell and Gene Therapies in Ophthalmology Summary Currently, there are eight cell and gene therapies (CGTs) on the market for various ophthalmology indications. These comprise Spark Therapeutics' Luxturna (voretigene neparvovec), which is indicated for retinitis pigmentosa (retinitis) and Leber conge ... Read More

• Generic Drugs (Physician Perspective) - Thematic Research

  Mar 28, 2024  |  Published by: GlobalData  |  USD 1,495

  Generic Drugs (Physician Perspective) - Thematic Research Summary Generic drugs are touted as an effective cost-containment measure for healthcare systems that often have outdated or ineffective financing mechanisms. By bypassing the extensive clinical studies required for branded medicines, generic ... Read More

• Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023

  Mar 27, 2024  |  Published by: GlobalData  |  USD 695

  Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023 Summary This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023. Scope The clinical trials data used for these analyses were extracted from GlobalData’s Clinical ... Read More

• Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) - Global Clinical Trials Review, 2024 provides an overview of Arthralgia (Joint Pain) Clinical trials scenario. This report provides top line data relating to the clinic ... Read More

• Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data rela ... Read More

• Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2024 provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line ... Read More

• Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 provides an overview of Borderline Personality Disorder (BPD) Clinical trials scenario. This report pro ... Read More

• Bronchiectasis - Global Clinical Trials Review, 2024

  Mar 25, 2024  |  Published by: GlobalData  |  USD 2,500

  Bronchiectasis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Bronchiectasis - Global Clinical Trials Review, 2024 provides an overview of Bronchiectasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis ... Read More

< prev 11 12 13 14 15 16 17 18 19 20 next >